logo
BSE:500124 logo

Dr. Reddy's Laboratories Community

BSE:500124 Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 22 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

500124 logo
Dr. Reddy's Laboratories
AN
AnalystConsensusTarget
Consensus Narrative from 38 Analysts

Investments In Biosimilars And NRT Will Expand Market Reach, Yet Regulatory Hurdles May Persist

Key Takeaways Strategic expansion in biosimilars and key product markets could drive revenue and improve margins. Increased investment in R&D for complex generics and GLP-1 assets aims to boost high-margin, innovative product offerings.
View narrative
₹1.32k
FV
10.5% undervalued intrinsic discount
6.22%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
3 days ago author updated this narrative